Description
TEMPORARY CONTRACT EXTENSION
Base award description: 65IB-DRUGS, PHARMACEUTICALS, AND HEMATOLOGY PRODUCTS
Modification chain · 29 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-04-04+$0= $0
- Mod P000012014-05-20+$0= $0
- Mod P000022014-05-21+$0= $0
- Mod P000032014-06-03+$0= $0
- Mod P000042014-08-06+$0= $0
- Mod P000052014-11-24+$0= $0
- Mod P000082014-12-11+$0= $0
- Mod P000102015-01-13+$0= $0
- Mod P000072015-05-22+$0= $0
- Mod P000132015-08-25+$0= $0
- Mod P000142015-12-11+$0= $0
- Mod P000172016-11-09+$0= $0
- Mod P000182016-12-12+$0= $0
- Mod P000162016-12-16+$0= $0
- Mod P000192017-07-19+$0= $0
- Mod P000202017-11-16+$0= $0
- Mod P000212017-11-28+$0= $0
- Mod P000222018-03-30+$0= $0
- Mod P000232018-12-10+$0= $0
- Mod P000242019-03-14+$0= $0
- Mod P000252019-03-21+$0= $0
- Mod P000262019-11-08+$0= $0
- Mod P000272019-11-14+$0= $0
- Mod P000292019-12-21+$0= $0
- Mod P000282020-01-23+$0= $0
- Mod P000302020-02-12+$0= $0
- Mod P000312020-04-27+$0= $0
- Mod P000322020-06-18+$0= $0
- Mod P000332020-07-22+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-04-04 | +$0 | $0 | 65IB-DRUGS, PHARMACEUTICALS, AND HEMATOLOGY PRODUCTS |
| Mod P00001· UNIQUE ENTITY ID OR LEGAL BUSINESS NAME CHANGE - NON-NOVATION | 2014-05-20 | +$0 | $0 | NOVATION-NAME CHANGE (CHIESI USA) |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2014-05-21 | +$0 | $0 | ADMINISTRATIVE CHANGE OF SIGNATORY AUTHORITY |
| Mod P00003· OTHER ADMINISTRATIVE ACTION | 2014-06-03 | +$0 | $0 | PERMANENT PRICING OF SPECIALTY (BETHKIS) |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2014-08-06 | +$0 | $0 | ADDING NEW PACKAGE SIZES FOR (BETHKIS) |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2014-11-24 | +$0 | $0 | DELETION MODIFICATION |
| Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2014-12-11 | +$0 | $0 | PUBLIC LAW UPDATE 2015 |
| Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2015-01-13 | +$0 | $0 | BILATERAL MOD (P00010) ISSUED TO INCORPORATE PERMANENT PRICE REDUCTION FOR ALL FSS USERS-APPLICABLE TO NDC 101… |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2015-05-22 | +$0 | $0 | PRICE DECREASE FOR BETHKIS (56) |
| Mod P00013· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2015-08-25 | +$0 | $0 | ADMINISTRATIVE CHANGE |
| Mod P00014· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2015-12-11 | +$0 | $0 | PUBLIC LAW 102-585 PRICING UPDATES |
| Mod P00017· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2016-11-09 | +$0 | $0 | ADMINISTRATIVE / IFF/ SALES REPORT POC: MONA WATKINS / TELL: 919-678-6698 / EMAIL: MONA.WATKINS@CHIESI.COM |
| Mod P00018· OTHER ADMINISTRATIVE ACTION | 2016-12-12 | +$0 | $0 | PUBLIC LAW 2017 |
| Mod P00016· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2016-12-16 | +$0 | $0 | 42-2A PRODUCT ADDITION (3) ITEMS (NDC/NAME/DOSAGE): 65293-0003-10 / KENGREAL / 50MG/10ML; 65293-0005-55 /CLEV… |
| Mod P00019· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-07-19 | +$0 | $0 | 42-2A NDC CHANGE (2) NDCS. |
| Mod P00020· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-11-16 | +$0 | $0 | 2018 PL UPDATES |
| Mod P00021· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-11-28 | +$0 | $0 | 42-2A NDC CHANGE |
| Mod P00022· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-03-30 | +$0 | $0 | PRODUCT DELETION |
| Mod P00023· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-12-10 | +$0 | $0 | 2019 PUBLIC LAW UPDATES |
| Mod P00024· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-03-14 | +$0 | $0 | PRODUCT ADDITION (TEMP FCP STAGE) |
| Mod P00025· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-03-21 | +$0 | $0 | TEMPORARY CONTRACT EXTENSION |
| Mod P00026· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-11-08 | +$0 | $0 | TEMPORARY CONTRACT EXTENSION |
| Mod P00027· OTHER ADMINISTRATIVE ACTION | 2019-11-14 | +$0 | $0 | PRODUCT DELETION |
| Mod P00029· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-12-21 | +$0 | $0 | PUBLIC LAW 2020 PRICING UPDATE |
| Mod P00028· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-01-23 | +$0 | $0 | PRODUCT DESCRIPTION CHANGE |
| Mod P00030· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-02-12 | +$0 | $0 | PRODUCT DELETION |
| Mod P00031· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-04-27 | +$0 | $0 | TEMPORARY CONTRACT EXTENSION |
| Mod P00032· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-06-18 | +$0 | $0 | PRODUCT ADDITION |
| Mod P00033· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-07-22 | +$0 | $0 | TEMPORARY CONTRACT EXTENSION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI M3FAV5PM8B15)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79726A0025 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24522N0311 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $13,551 | FY2022 |
| 36E79721A0020 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2021 |
| 36C25821N0374 | 258-NETWORK CNTRCT OFF 22G (36C258) · 6505 · DRUGS AND BIOLOGICALS | $75,951 | FY2021 |
| 36C24521F0516 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $31,646 | FY2021 |
| 36C24521F0489 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $18,988 | FY2021 |
Other recipients under 6505 from NAC FEDERAL SUPPLY SCHEDULE (36F797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36F79726D058E | REVOLUTION MEDICINES, INC. | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0172 | LUNDBECK LLC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0195 | MILESTONE PHARMACEUTICALS USA, INC. | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0165 | RECKITT BENCKISER LLC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0118 | OMEROS CORPORATION | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_V797D40132_3600 · retrieved 2026-09-26.